These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36809055)

  • 1. Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification.
    Tshiaba PT; Ratman DK; Sun JM; Tunstall TS; Levy B; Shah PS; Weitzel JN; Rabinowitz M; Kumar A; Im KM
    JCO Precis Oncol; 2023 Feb; 7():e2200447. PubMed ID: 36809055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
    Hughes E; Tshiaba P; Wagner S; Judkins T; Rosenthal E; Roa B; Gallagher S; Meek S; Dalton K; Hedegard W; Adami CA; Grear DF; Domchek SM; Garber J; Lancaster JM; Weitzel JN; Kurian AW; Lanchbury JS; Gutin A; Robson ME
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
    Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
    Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic Breast Cancer Risk for Women Veterans in the Million Veteran Program.
    Minnier J; Rajeevan N; Gao L; Park B; Pyarajan S; Spellman P; Haskell SG; Brandt CA; Luoh SW
    JCO Precis Oncol; 2021 Jul; 5():. PubMed ID: 34381935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors.
    Mabey B; Hughes E; Kucera M; Simmons T; Hullinger B; Pederson HJ; Yehia L; Eng C; Garber J; Gary M; Gordon O; Klemp JR; Mukherjee S; Vijai J; Offit K; Olopade OI; Pruthi S; Kurian A; Robson ME; Whitworth PW; Pal T; Ratzel S; Wagner S; Lanchbury JS; Taber KJ; Slavin TP; Gutin A
    Genet Med; 2024 Jul; 26(7):101128. PubMed ID: 38829299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry.
    Du Z; Gao G; Adedokun B; Ahearn T; Lunetta KL; Zirpoli G; Troester MA; Ruiz-Narváez EA; Haddad SA; PalChoudhury P; Figueroa J; John EM; Bernstein L; Zheng W; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Mancuso N; Press MF; Deming SL; Rodriguez-Gil JL; Yao S; Ogundiran TO; Ojengbe O; Bolla MK; Dennis J; Dunning AM; Easton DF; Michailidou K; Pharoah PDP; Sandler DP; Taylor JA; Wang Q; Weinberg CR; Kitahara CM; Blot W; Nathanson KL; Hennis A; Nemesure B; Ambs S; Sucheston-Campbell LE; Bensen JT; Chanock SJ; Olshan AF; Ambrosone CB; Olopade OI; Yarney J; Awuah B; Wiafe-Addai B; Conti DV; ; Palmer JR; Garcia-Closas M; Huo D; Haiman CA
    J Natl Cancer Inst; 2021 Sep; 113(9):1168-1176. PubMed ID: 33769540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
    Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study.
    Ohbe H; Hachiya T; Yamaji T; Nakano S; Miyamoto Y; Sutoh Y; Otsuka-Yamasaki Y; Shimizu A; Yasunaga H; Sawada N; Inoue M; Tsugane S; Iwasaki M;
    Breast Cancer Res Treat; 2023 Feb; 197(3):661-671. PubMed ID: 36538246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
    Liu C; Zeinomar N; Chung WK; Kiryluk K; Gharavi AG; Hripcsak G; Crew KD; Shang N; Khan A; Fasel D; Manolio TA; Jarvik GP; Rowley R; Justice AE; Rahm AK; Fullerton SM; Smoller JW; Larson EB; Crane PK; Dikilitas O; Wiesner GL; Bick AG; Terry MB; Weng C
    JAMA Netw Open; 2021 Aug; 4(8):e2119084. PubMed ID: 34347061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among Asian Women.
    Yang Y; Tao R; Shu X; Cai Q; Wen W; Gu K; Gao YT; Zheng Y; Kweon SS; Shin MH; Choi JY; Lee ES; Kong SY; Park B; Park MH; Jia G; Li B; Kang D; Shu XO; Long J; Zheng W
    JAMA Netw Open; 2022 Mar; 5(3):e2149030. PubMed ID: 35311964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
    Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
    Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease.
    Mosley JD; Gupta DK; Tan J; Yao J; Wells QS; Shaffer CM; Kundu S; Robinson-Cohen C; Psaty BM; Rich SS; Post WS; Guo X; Rotter JI; Roden DM; Gerszten RE; Wang TJ
    JAMA; 2020 Feb; 323(7):627-635. PubMed ID: 32068817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps.
    Subramanian J; Karmegam A; Papageorgiou E; Papandrianos N; Vasukie A
    Comput Methods Programs Biomed; 2015 Mar; 118(3):280-97. PubMed ID: 25697987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.
    Wang S; Qian F; Zheng Y; Ogundiran T; Ojengbede O; Zheng W; Blot W; Nathanson KL; Hennis A; Nemesure B; Ambs S; Olopade OI; Huo D
    Breast Cancer Res Treat; 2018 Apr; 168(3):703-712. PubMed ID: 29302764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
    Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
    J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.